SV Life Sciences Closes $523M Fund

Xconomy Boston — 

SV Life Sciences, a Boston-based venture firm focused on healthcare investments, said today it has closed its latest Fund V at $523 million. VentureWire reported today this fund is the second-largest healthcare fund raised in 2010, after the $550 million fund that OrbiMed Advisors closed early this year. SV Life Sciences says that it plans to use its new fund to invest in therapeutics, medical devices, diagnostics, healthcare services, and health IT. And the size of its investments will be between $5 million and $35 million. The firm also has a Bay Area office in Foster City and a European office in London.